DIA Appoints Marwan Fathallah as President and Global Chief Executive
DIA Appoints New Leadership
WASHINGTON, February 08, 2023--(BUSINESS WIRE)--DIA, founded as the Drug Information Association, announced today that it has named Marwan Fathallah as President and Global Chief Executive. Mr. Fathallah will lead the organization to help drive thought leadership and innovation in therapeutic development to improve the health of people worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230130005697/en/
Marwan Fathallah, DIA President and Global Chief Executive (Photo: Business Wire)
"Marwan is well positioned to build on our mission, execute our vision and lead DIA successfully into the future," said DIA Board Chair, Dr. Cynthia Verst. "He is a transformative and growth-minded leader who is ready to rise to the challenge of a new era for healthcare as we all work together to solve the most pressing concerns ahead of us."
Most recently he was Operating Officer and Executive Vice President at Ortho Clinical Diagnostics.
His broad ranging global experience spans 30 years ranging from operations, end-to-end supply chain, manufacturing, research and development, quality and regulatory, clinical, medical affairs and commercial execution in the Life Science, Pharmaceutical, Medical Device, Drug Delivery and Diagnostics industries.
"I am honored to join DIA as its next President and Global Chief Executive. There has never been a more important time to continue DIA’s legacy of furthering better global health outcomes," said Mr. Fathallah. "I look forward to working with the dedicated staff, Board of Directors, advisory councils, Fellows, and volunteers who all help to make DIA the impactful organization it is."
Fathallah holds a master’s degree in mechanical engineering from the University of Wisconsin-Madison and a Master of Business Administration from the Kellogg School of Management at Northwestern University. He has served on the board for the biomedical engineering department at the University of Wisconsin-Madison and holds more than 25 patents for drug delivery and medical products.
DIA (founded as the Drug Information Association) is a global association that mobilizes life science professionals from across all areas of expertise to engage with patients, peers and thought leaders in a neutral environment on the issues of today and the possibilities for tomorrow. As a member-driven, volunteer organization, professionals from 80 countries have affected healthcare outcomes, by engaging with DIA through an unparalleled network, educational offerings, and professional development opportunities.
DIA is based in Washington, DC (US) with regional offices representing the Americas (Horsham, PA, US); Europe, the Middle East, and Africa, (Basel, Switzerland); and Asia (Beijing and Shanghai, China; Mumbai, India; and Tokyo, Japan). DIA's members come together to collaborate and problem-solve, discussing global and local challenges facing the life sciences field in an increasingly more complex and interconnected world. DIA's goal, and our members' hope, is for this collaboration to result in better policies, regulations, science, research and development, and ultimately better patient outcomes worldwide.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230130005697/en/